La cadena de opciones muestra datos clave de las opciones de acciones de Target Hospitality a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Target Hospitality..

Target Hospitality (NASDAQ:TH) Bolsa, Cadena de Opciones

Target Hospitality

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. Its operating segment includes HFS-South and HFS-Midwest; Government; TCPL Keystone and others. It generates a majority of its revenue from the Government segment which consists of specialty rental and vertically integrated hospitality services revenue from customers with Government contracts located in Texas.

Target Hospitality Corp

THORESEN THAI AGS FGN REG by Thoresen Thai Agencies Public Co., Ltd.

Thoresen Thai Agencies PCL

THORESEN THAI AGENCS NVDR by Thoresen Thai Agencies Public Co., Ltd.

Tharimmune Inc

Third Bench Inc

TURKIYE HALK BANKASI by Turkiye Halk Bankasi A.S.

Turkiye Halk Bankasi AS

THUNDERBIRD ENTRTNMT GRP by Thunderbird Entertainment Group Inc.

Thunderbird Entertainment Group Inc

Tenet Healthcare Corporation Common Stock

Tenet Healthcare Corp

THC BIOMED INTL LTD ORD by THC BioMed Intl Ltd.

THC Biomed International Ltd

TH International Limited - Ordinary shares

TH International Ltd

TOHO CO LTD ADR by TOHO CO LTD.

THUNDER BRDG CAP PARTNERS IV INC CL A

THUNDER BRDG CAP PARTNERS IV INC UNIT 1 CL A & 1/5 WT EXP

THUNDER BRDG CAP PARTNERS IV INC WT EXP

THC THERAPEUTICS INC by THC Therapeutics, Inc.

THC Therapeutics Inc

Spinnaker ETF Series Cannabis ETF

iShares Inc iShares MSCI Thailand ETF

TV ASAHI HLDGS CORP U/ADR by TV Asahi Holdings Corp.

TV Asahi Holdings Corp

THE ONE ENT PCL NVDR by The One Enterprise PCL

3Dshopping.com Inc

THERMADOR GROUPE SA by Thermador Groupe SA

Thermador Groupe SA

T. Rowe Price Exchange-Traded Funds, Inc. T. Rowe Price Hedged Equity ETF

THERALINK TECHNOLOGIES by Theralink Technologies Inc.

Theralink Technologies Inc

Theta - United States Dollar

First Financial Corporation - Common Stock

First Financial Corp

THAI UN GRP FOREIGN REG by Thai Union Group Public Company Limited

Thai Union Group PCL

Thorpe (F W) PLC

The Hanover Insurance Group Inc

Thetan Arena

THG HLDGS PLC UNSP/ADR by THG Holdings PLC.

THG PLC

TECHNO HORIZON CO LTD by Techno Horizon Co Ltd.

Techno Horizon Co Ltd

THOR Financial Technologies Trust THOR Index Rotation ETF

Think Research Corp Ordinary Shares

THK Co Ltd

Thales

LEHMAN (T H) CO INC by Lehman (T.H.) & Co., Inc.

Thule Group AB

THOR Equal Weight Low Volatility ETF

International Tower Hill Mines, Ltd. Ordinary Shares (Canada)

International Tower Hill Mines Ltd

THUNDER MOUNTAIN GOLD INC by Thunder Mountain Gold, Inc.

Thunder Mountain Gold Inc

THAICOM PUBLIC CO ORD by Thaicom Public Co., Ltd.

THERMOGENESIS HLDGS INC by ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings Inc

Lazard Equity Megatrends ETF

Throne

TECHNOPROBE SPA U/ADR by TECHNOPROBE SPA

THINKIFIC LABS INC SUB VT by Thinkific Labs Inc.

Thinkific Labs Inc

Thorn Group Ltd

TECHNOLOGY ONE LTD by Technology One, Ltd.

Technology One Ltd

TECHNIP ENERGIES NV by Technip Energies NV

Technip Energies NV

TECHNIP ENERGIES S/ADR by Technip Energies NV

ROBO Global Artificial Intelligence ETF

Amplify ETF Trust Amplify Weight Loss Drug & Treatment ETF

THANACHART CAP UNSP/ADR by Thanachart Capital Public Co., Ltd.

Thanachart Capital PCL

THANACHART CAP PCL ORD by Thanachart Capital Public Co., Ltd.

Thor Industries Inc

TOHO GAS CO LTD ORD NEW by Toho Gas Co., Ltd.

Toho Gas Co Ltd

TOHO Co Ltd

THAI OIL PCL UTS NVDR by Thai Oil Public Co., Ltd.

Thai Oil PCL

Thor Energy PLC

Bioporto AS

Thinkpath Inc

Toho Holdings Co Ltd

Techpoint Inc

abrdn Healthcare Opportunities Fund Shares of Beneficial Interest

abrdn Healthcare Opportunities Fund

Embracer Group AB

Thermon Group Holdings, Inc. Common Stock

Thermon Group Holdings Inc

Therma-Med Inc

Third Harmonic Bio Inc

Thai Reinsurance PCL

Gentherm Inc

THORNE HEALTHTECH INC COM

iShares U.S. Thematic Rotation Active ETF

Thor Energy PLC Shs CHESS Depository Interests

THRESHER INDUSTRIES INC by Thresher Industries, Inc.

Thresher Industries Inc

Thunderbird Resorts Inc

INTELLIGENT MONITRING GRP by Intelligent Monitoring Group Ltd,

Intelligent Monitoring Group Ltd

THESEUS PHARMACEUTICALS INC COM

Thryv Holdings Inc

Treehouse Foods Inc

Thesis Gold Inc

THUS GROUP PLC UNSPON ADR by Thus Group Plc

Truett-Hurst Inc Class A

Tidal ETF Trust SoFi Enhanced Yield ETF

Theratechnologies Inc

THULE GROUP AB UNSP/ADR by Thule Group AB

Thunderstruck Resources Ltd

THUNDERSTRUCK RES LTD by Thunderstruck Resources Ltd

THOMASVILLE BNCSHS INC by Thomasville Bancshares, Inc.

Thomasville Bancshares Inc

abrdn World Healthcare Fund Shares of Beneficial Interest

Tekla World Healthcare Fund

Target Hospitality Corp Warrants (15/03/2024)

THOR EXPLORATION LTD by THOR EXPLORATION LTD.

Thor Explorations Ltd

Toews Agility Shares Dynamic Tactical Income ETF

TAIHEIYO CEMENT CORP NEW by Taiheiyo Cement Corp.

Taiheiyo Cement Corp

TAIHEYO CEMENT CORP S/ADR by Taiheiyo Cement Corp.

ASTE

Astec Enters Into Definitive Agreement to Acquire TerraSource Holdings For $245M; Anticipates Adj. EBITDA Multiple Of 5.9x Adjusted For Expected Tax Benefits Of ~$15M And Annual Run-Rate Synergies ~$10M By End Of Year Two

S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) reported quarterly earnings of $4.37 per share which beat the analyst consensus estimate of $4.19 by 4.3 percent. This is a 8.98 percent increase over earnings of $4.01 per share from the same period last year. The company reported quarterly sales of $3.78 billion which beat the analyst consensus estimate of $3.70 billion by 2.13 percent. This is a 8.19 percent increase over sales of $3.49 billion the same period last year.

Earnings

Earnings Beats

News

SPGI

S&P Global Q1 Adj. EPS $4.37 Beats $4.19 Estimate, Sales $3.78B Beat $3.70B Estimate

Findings from ALAMO Study Show AlloSure Lung is Associated with Prognosis of Chronic Lung Allograft Dysfunction and Restrictive Allograft Syndrome
AlloSure Lung Surveillance Monitoring Identifies the Onset of Acute Cellular Rejection and Treatment Response
CareDx, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNA#NASDAQ">CDNA</a>) – The Transplant Company&#x2122; – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that CareDx, together with study collaborators, presented new scientific evidence on the use of AlloSure&#xAE; Lung in clinical practice at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting &amp; Scientific Sessions, held from April 27-30 in Boston, Massachusetts.

CDNA

Caredx Presents New Scientific Evidence On Use Of Allosure Lung In Clinical Practice At ISHLT 45Th Annual Meeting & Scientific Sessions

General

Linde To Increase Its Supply Of Industrial Gases To Samsung In South Korea

H&amp;E Equipment Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEES#NASDAQ">HEES</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.63 by 95.24 percent. This is a 95.77 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $319.45 million which missed the analyst consensus estimate of $362.60 million by 11.90 percent. This is a 13.98 percent decrease over sales of $371.36 million the same period last year.

Earnings Misses

HEES

H&E Equipment Servs Q1 Adj. EPS $0.03 Misses $0.63 Estimate, Sales $319.45M Miss $362.60M Estimate

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the communication services sector.
<h3 class="wp-block-heading">Playtika Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTK#NASDAQ">PLTK</a>)</h3>
<ul>
<li>Dividend Yield: 7.65%</li>
<li>Morgan Stanley analyst Matthew Cost maintained an Equal-Weight rating and cut the price target from $7.25 to $5.75 on April 17, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Citigroup analyst Jason Bazinet maintained a Buy rating and lowered the price target from $10 to $9 on March 7, 2025. This analyst has an accuracy rate of 71%.</li>
<li>Recent News: Playtika Holding will release financial results for the first quarter before the opening bell on Thursday, May 8.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">PLTK news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="912" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209.png" alt="" class="wp-image-892557" style="width:550px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071054/image-209-768x709.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">NetEase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTES#NASDAQ">NTES</a>)</h3>
<ul>
<li>Dividend Yield: 2.46%</li>
<li>Barclays analyst Jiong Shao maintained an Equal-Weight rating and raised the price target from $82 to $104 on Feb. 24, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Benchmark analyst Fawne Jiang maintained a Buy rating and raised the price from $105 to $115 on Feb. 21, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On April 15, NetEase announced filing of annual report on Form 20-F for fiscal year 2024.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest NTES <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="903" height="850" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210.png" alt="" class="wp-image-892559" style="width:526px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210.png 903w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071138/image-210-768x723.png 768w" sizes="(max-width: 903px) 100vw, 903px" /></a></figure>
<h3 class="wp-block-heading">AT&amp;T Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/T#NYSE">T</a>)</h3>
<ul>
<li>Dividend Yield: 4.07%</li>
<li>Barclays analyst Kanan Venkateshwar maintained an Overweight rating and raised the price target from $27 to $30 on April 25, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Morgan Stanley analyst Simon Flannery maintained an Overweight rating and raised the price target from $30 to $31 on April 24, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Recent News: On April 23, the telecom giant reported quarterly operating revenues of $30.63 billion, up 2.0% year over year. This beat the analyst consensus estimate of $30.35 billion. Adjusted EPS of $0.51 also beat the analyst consensus estimate of $0.49.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429">latest T news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0429"><img loading="lazy" decoding="async" width="907" height="815" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211.png" alt="" class="wp-image-892560" style="width:532px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211-300x270.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/29071212/image-211-768x690.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/25/04/45060164/general-motors-coca-cola-and-3-stocks-to-watch-heading-into-tuesday">General Motors, Coca-Cola And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Price Target

Pre-Market Outlook

Markets

Analyst Ratings

Trading Ideas

NTES

PLTK

Wall Street's Most Accurate Analysts Weigh In On 3 Tech And Telcom Stocks Delivering High-Dividend Yields

Correction : Rosenblatt analyst Barton Crockett initiates coverage on Viant Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSP#NASDAQ">DSP</a>) with a Buy rating and announces Price Target of $20.(Rating changed)

Initiation

Correction : Rosenblatt Initiates Coverage On Viant Technology with Buy Rating, Announces Price Target of $20 (Rating changed)

On Monday, April 28, U.S. markets closed mixed, with the S&amp;P 500 and Dow posting modest gains while the Nasdaq dipped. Weakness in mega caps like Nvidia and Amazon weighed on sentiment as investors awaited major tech earnings and key economic data. Uncertainty around trade policies and Sino-U.S. negotiations kept markets cautious despite recent stabilization.
In economic data, the Dallas Fed reported that Texas manufacturing activity weakened in April, with its general business activity index falling by 19.5 points to -35.8.
Most S&amp;P 500 sectors advanced Monday, led by real estate, energy, and utilities, while consumer staples and tech lagged.
The Dow Jones Industrial Average was up 0.28% to 40,227.59, the S&amp;P 500 rose 0.06% to 5,528.75, while the Nasdaq declined 0.10% to 17,366.13.
Asia Markets Today
<ul>
<li>Japan's market closed for the Showa Day holiday.</li>
<li>On Tuesday, Australia's S&amp;P/ASX 200 gained 0.92%, ending the session at 8,070.60, led by gains in the Energy, Utilities, and Resources sectors.</li>
<li>India's Nifty 50 was up 0.05% at 24,336.50, and Nifty 500 rose 0.09% to 22,122.25.</li>
<li>China's Shanghai Composite slid 0.05% to 3,286.65, and Shanghai Shenzhen CSI 300 was down 0.17% at 3,775.08.</li>
<li>Hong Kong's Hang Seng closed 0.18% higher at 22,008.11.</li>
</ul>
Eurozone at 05:45 AM ET
<ul>
<li>The European STOXX 50 index was up 0.02%.</li>
<li>Germany's DAX index gained 0.79%.</li>
<li>France's CAC 40 slid 0.03%.</li>
<li>U.K.'s FTSE 100 index traded higher by 0.09%.</li>
</ul>
Commodities at 05:45 AM ET
<ul>
<li>Crude Oil WTI was trading lower by 1.24% at $61.28/bbl, and Brent was down 1.28% at $63.96/bbl.</li>
<li>Crude oil prices fell as U.S.-China trade tensions weakened demand expectations. OPEC+ output talks, refinery outages, and rising U.S. stockpiles added further pressure on prices.</li>
<li>Natural Gas fell 0.63% to $3.322.</li>
<li>Gold was trading lower by 0.80% at $3,320.89, Silver was up 0.93% to $33.313, and Copper rose 1.228% to $4.9516.</li>
<li>Gold prices fell as easing U.S. auto tariffs calmed trade fears.</li>
</ul>
U.S. Futures at 05:45 AM ET
Dow futures were up 0.22%, S&amp;P 500 futures gained 0.15 %, and Nasdaq 100 futures rose 0.19%.
Forex at 05:45 AM ET
<ul>
<li>The U.S. Dollar Index rose 0.33% to 99.26, USD/JPY was up 0.49% to 142.71, and USD/AUD gained 0.24% to 1.5586.</li>
<li>The U.S. dollar edged higher but remained on track for a sharp monthly loss amid tariff uncertainty and economic slowdown fears, while investors awaited key U.S. data and global trade updates.</li>
</ul>
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed, Gold Dips On Trade Truce Hope  - Global Markets Today While US Slept

ZAPP

Zapp EV Expands Into Ireland With Appointment Of First Authorised Reseller In Dublin

Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) is looking for Q2 Adj EPS of $0.55-$0.59 vs $0.56 analyst estimate. sees sales of $3.850 billion vs $3.82 billion analyst estimate.

Guidance

Corning Sees Q2 Adj EPS $0.55-$0.59 vs $0.56 Est; Sees Core Sales $3.850B vs $3.82B Est

Rosenblatt analyst Barton Crockett initiates coverage on Magnite (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGNI#NASDAQ">MGNI</a>) with a Buy rating and announces Price Target of $18.

MGNI

Rosenblatt Initiates Coverage On Magnite with Buy Rating, Announces Price Target of $18

Outlook
"In the first quarter we saw booking strength from January deteriorate into February and worsen into March," said Marty St. George, JetBlue's president. "We expect softened demand for off-peak travel to continue into the second quarter, where the booking curve is more exposed to macro uncertainty and deteriorating consumer confidence. That said, we are committed to our JetForward plan and are encouraged by the resiliency of premium, international, and loyalty revenues - core components of our long-term strategy."
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Second Quarter and Full Year 2025 Outlook</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Estimated 2Q 2025</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Estimated FY 2025</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Available Seat Miles ("ASMs") Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(3.5%) - (0.5%)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">RASM Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">(7.5%) - (3.5%)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">CASM Ex-Fuel (1), (2) Year-Over-Year</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">6.5% - 8.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Fuel Price per Gallon (3), (4)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$2.25 - $2.40</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Interest Expense</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$600 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$400 million</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">~$1.3 billion</td>
</tr>
</tbody>
</table>
</figure>

JBLU

JetBlue Expects Q2 2025 Available Seat Miles Year-Over-Year Decline Of (3.5%)-(0.5%)

<a href="https://www.globenewswire.com/Tracker?data=k_AP_7XwuO_5EvdiadgYRFP1KPG3qzFhiqX_4zqt3CDb9xzai6sghaCP31YDkTwxUUtoLxQbVADKnGnRFMYl4ACebhgINwmMpoD72kF-kCs=">Pasithea Therapeutics Corp.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTTA#NASDAQ">KTTA</a>) ("Pasithea" or the "Company"), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis type 1 (NF1) and other MAPK pathway driven cancer indications, today announced the Company has completed enrollment and initial dosing of three subjects in Cohort 6 with 30 mg capsules of PAS-004.
The ongoing Phase 1 clinical trial is a multi-center, open-label, dose escalation 3+3 study design to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of PAS-004 in patients with MAPK pathway driven advanced solid tumors with a documented RAS, NF1 or RAF mutation or patients who have failed BRAF/MEK inhibition (<a href="https://www.globenewswire.com/Tracker?data=egYAj5B3mYmpOUcK43ywwcGpLB2F9iZ-eYuWoa7kAJ2DEbDIoZyJn5QkulzNtWo810-AKcngoFR72fmYBaqr563TQG-3O60UH-79X1hJdMLIKaG0LK8wjAx9eDccTjkx">NCT06299839</a>).
 &nbsp;

KTTA

Pasithea Therapeutics Completes Enrollment And Initial Dosing Of Three Subjects In Cohort 6 With 30 Mg Capsules Of PAS-004

Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLW#NYSE">GLW</a>) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.51 by 5.88 percent. This is a 42.11 percent increase over earnings of $0.38 per share from the same period last year. The company reported quarterly sales of $3.68 billion which beat the analyst consensus estimate of $3.64 billion by 0.98 percent. This is a 12.92 percent increase over sales of $3.26 billion the same period last year.

Comments

Target Hospitality

Target Hospitality (TH) Opciones

Target Hospitality (NASDAQ:TH) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL